Cargando…
Can roflumilast become steroid-sparing alternative in the treatment of COVID-19?
According to WHO the worst of the COVID-19 pandemic is yet to come. Despite of the exceptional measures being undertaken by regulatory agencies to expedite vaccine development, we may be several months if not years away from an effective vaccine. In such unprecedented times, the only resort nations...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470720/ https://www.ncbi.nlm.nih.gov/pubmed/33254551 http://dx.doi.org/10.1016/j.mehy.2020.110246 |